SynthesisFrontiers in psychiatry2025
Effects of mindfulness-based interventions on insight and stigma in patients with schizophrenia: a systematic review and meta-analysis.
Synthesis in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Moderating Role of Social Functioning in the Relationship Between Stigma and Quality of Life in Rural Chinese Patients with Schizophrenia: A Cross-Sectional Study.Neuropsychiatric disease and treatment · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To systematically evaluate the impact of mindfulness-based interventions on insight and stigma in patients with schizophrenia. Methods: Randomized controlled trials (RCTs) and quasi-randomized controlled trials investigating the effects of mindfulness-based interventions on insight and stigma in schizophrenia patients were retrieved from databases including CNKI, Wanfang, VIP, CBM, PubMed, Cochrane Library, Embase, and Web of Science, with the search period spanning from inception to June 2025. Statistical analysis was performed using RevMan 5.2 software, with effect sizes expressed as standardized mean difference (SMD) and 95% confidence interval (CI). Heterogeneity was assessed using the I² statistic: a random-effects model was applied when I² ≥ 50% or P < 0.05; otherwise, a fixed-effects model was used. To evaluate the impact of study design on pooled effects, a case-deletion sensitivity analysis was conducted. Publication bias was assessed using funnel plots and Egger's test. Intervention types included mindfulness-based stress reduction, mindfulness-based cognitive therapy, group mindfulness therapy, and mindfulness-informed psychoeducation/skills training, with intervention durations ranging from 4 to 24 weeks. Results: A total of 11 RCTs and 2 quasi-randomized controlled trials involving 2,899 patients were included. The analysis revealed that the intervention group exhibited significantly better insight (SMD=1.05, 95% CI=0.67-1.43, P < 0.00001) and lower stigma (SMD=-0.81, 95% CI=-1.00 to -0.63, P < 0.00001) compared to the control group. Conclusion: Mindfulness-based interventions can significantly improve insight and reduce stigma in patients with schizophrenia, holding important clinical implications. Specifically, they may enhance treatment adherence and rehabilitation participation, decrease self-stigma, and promote the restoration of social functioning. Higher-quality, long-term follow-up randomized controlled trials (RCTs) are still needed to further validate and refine the evidence. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, PROSPERO identifier CRD420251172478.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.